Replace, Reduce, Refine – More ethics in animal testing for tomorrow’s medicine

Interview with: Prof. Jens Kurreck, TU Berlin and Director of the 3R Center Berlin

More

Kupando raises €13 million in Series A funding round

Financing led by Remiges Ventures, co-led by LifeCare Partners, with additional investments by Brandenburg Kapital, High-Tech Gründerfonds, Ventura Biomed Investors and undisclosed family offices.

Proceeds to be used to complete IND-enabling work…

More

NUVISAN receives US$ 9.6m grant for a multi-target drug discovery program on novel non-hormonal contraceptive medicines

NUVISAN’s integrated drug discovery expertise leveraged in a grant from the Bill & Melinda Gates Foundation

More

The predictive power of blood – Metabolomic profiling reveals risk of multiple diseases all at once

To prevent diseases from occurring in the first place, it is important to identify those individuals who are at particularly high risk as early as possible. Yet current screening methods are often costly and focus only on one disease at a time.…

More

Keeping aggressive cancer cells in check

BRCA1/2-mutated tumor cells often survive treatment, whether it’s chemo- or radiotherapy, because they can repair therapy-induced DNA damage. A team led by Claus Scheidereit of the Max Delbrück Center has now reported in The EMBO Journal how blocking…

More

SCIENION & Cellenion launch the proteoCHIP LF 48, for label-free single-cell proteomics sample preparation on the cellenONE® platform

Optimized sample preparation workflows facilitate single cell proteomics applications

More

When macrophage digestion goes wrong

If a secretion in the lungs’ alveoli is not cleared regularly, breathing difficulties can develop. In a study published in Science Immunology, a team led by Alexander Mildner and Achim Leutz has now explained the pivotal role of the transcription…

More

Aignostics Raises €14m Series A to Advance AI-powered Pathology

Oversubscribed financing round with top-tier life science investors, led by Wellington Partners | Spin-off from Charité – Universitätsmedizin Berlin developing sophisticated AI models to improve understanding, diagnosis and treatment of complex…

More

NextPharma and Takeda announce Future of Pharmaceutical Manufacturing Site in Asker, Norway

- NextPharma to Acquire Takeda’s Manufacturing Site in Asker, Norway

- The Asker Site No Longer Produces Finished Products for Takeda

- Deal Closing is Expected around March 2023

More

Neuroscientists from Charité have revealed the precise connections between sensory neurons inside the retina and a structure in the midbrain

New Neuropixels technology provides evidence of mosaic-like neural connections

 

More
Show more items